RedPoint Oncology Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 7

RedPoint Oncology General Information

Description

Developer of oncology therapeutics designed to target therapy-resistant cancers and improve patient outcomes. The company engineers modular payloads that induce specific forms of cell death and can be incorporated into antibody drug conjugates and other targeted delivery formats, enabling biopharmaceutical companies to create new treatments for difficult-to-treat cancers and improve patient survival and quality of life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 83 Parker Avenue
  • Holden, MA 01520
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 83 Parker Avenue
  • Holden, MA 01520
  • United States

RedPoint Oncology Timeline

20252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RedPoint Oncology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Early Stage VC Completed Startup
7. Accelerator/Incubator 09-Mar-2026 Completed Startup
6. Accelerator/Incubator 01-Jan-2026 Completed Startup
5. Accelerator/Incubator 16-Oct-2025 Completed Startup
4. Grant 22-May-2025 Completed Startup
3. Accelerator/Incubator 11-Apr-2025 Completed Startup
2. Accelerator/Incubator 26-Mar-2025 Completed Startup
1. Accelerator/Incubator 01-Jan-2025 Completed Startup
To view RedPoint Oncology’s complete valuation and funding history, request access »

RedPoint Oncology Patents

RedPoint Oncology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026226745-A1 Ferroptosis inducing compounds, compositions, and antibody-drug conjugates, and methods of use thereof Pending 24-Apr-2025

RedPoint Oncology Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Massachusetts Life Sciences Center Government
Termeer Institute Accelerator/Incubator
Endless Frontier Labs Accelerator/Incubator Minority
US National Science Foundation Accelerator/Incubator
Center for the Advancement of Science in Space Government
You’re viewing 5 of 7 investors. Get the full list »

RedPoint Oncology FAQs

  • When was RedPoint Oncology founded?

    RedPoint Oncology was founded in 2024.

  • Where is RedPoint Oncology headquartered?

    RedPoint Oncology is headquartered in Holden, MA.

  • What industry is RedPoint Oncology in?

    RedPoint Oncology’s primary industry is Drug Discovery.

  • Is RedPoint Oncology a private or public company?

    RedPoint Oncology is a Private company.

  • What is RedPoint Oncology’s current revenue?

    The current revenue for RedPoint Oncology is .

  • How much funding has RedPoint Oncology raised over time?

    RedPoint Oncology has raised $100K.

  • Who are RedPoint Oncology’s investors?

    Massachusetts Life Sciences Center, Termeer Institute, Endless Frontier Labs, US National Science Foundation, and Center for the Advancement of Science in Space are 5 of 7 investors who have invested in RedPoint Oncology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process